USG Joint Compound

Product Description

United States Gypsum Company (USG) is one of the longest-operating and most widely recognized manufacturers of construction materials in the United States. Among its extensive product line, USG produced a range of joint compounds—also commonly referred to as drywall mud or taping compound—that were used extensively throughout the construction industry during the mid-to-late twentieth century. These products were applied during the finishing stages of drywall installation to fill seams between gypsum wallboard panels, cover fastener dimples, and create smooth interior wall and ceiling surfaces.

USG joint compound was a staple material on residential, commercial, and industrial job sites across the country. The product was sold under various brand names and formulations over the decades, and it was considered an industry-standard finishing material by drywall contractors, plasterers, and construction tradespeople. Ready-mix and powder formulations were both available, and the compound was applied in multiple coats—typically a taping coat, a fill coat, and a finish coat—before being sanded smooth prior to painting.

The widespread use of USG joint compound on virtually every type of new construction and renovation project meant that the product reached an enormous number of workers and occupied buildings during the period when asbestos was commonly incorporated into building materials.

Asbestos Content

Litigation records document that USG incorporated chrysotile asbestos into certain formulations of its joint compound products. Plaintiffs alleged that asbestos fibers were added to joint compound mixtures as a reinforcing and binding agent, with the material’s fibrous structure lending tensile strength to the dried compound and helping to prevent cracking during the curing process.

Plaintiffs alleged that USG was aware of industry-wide concerns regarding asbestos use in joint compound products and that the company continued to manufacture and sell asbestos-containing formulations for a significant period despite the availability of alternative materials. Litigation records document that internal documents and industry correspondence were cited in proceedings as evidence of manufacturer knowledge regarding the hazards of asbestos-containing drywall finishing products.

The use of asbestos in joint compound was an industry-wide practice, not unique to USG, and regulatory scrutiny of asbestos in these products increased through the late 1970s. The Consumer Product Safety Commission took action in the mid-1970s specifically targeting asbestos-containing joint compounds, resulting in the phase-out of asbestos from new formulations. However, products manufactured and sold prior to that transition remained in use on job sites and in buildings for years afterward.

How Workers Were Exposed

Industrial workers and construction tradespeople who worked with or near USG joint compound during the years when asbestos-containing formulations were in use faced potential exposure to asbestos fibers through several distinct work processes.

Mixing powdered compound was among the most significant exposure pathways. Workers who opened bags of dry joint compound and mixed them with water in buckets or mechanical mixers could generate airborne dust containing asbestos fibers. Plaintiffs alleged that this dry-mixing process released respirable asbestos-containing particles directly into the breathing zone of workers performing the task.

Sanding dried compound represented another high-exposure activity. After joint compound was applied and allowed to cure, workers sanded the surface to achieve a smooth finish before painting. Hand sanding and mechanical pole sanding both created fine dust clouds. Litigation records document that sanding asbestos-containing joint compound was identified as one of the dustiest and most hazardous activities associated with drywall finishing work.

Application and feathering also involved direct handling of the material. Taping knife work, hawk and trowel application, and the hand-spreading required to achieve thin feathered edges all brought workers into close contact with the compound in ways that could disturb and aerosolize asbestos fibers, particularly when working with partially dried or disturbed material.

Bystander exposure was documented as well. Workers in adjacent trades—painters, electricians, plumbers, and others present on job sites during finishing work—could inhale asbestos-laden dust generated by drywall tapers without directly handling the joint compound themselves. Litigation records document claims brought by workers in multiple trades who alleged secondary or bystander exposure on shared job sites.

Renovation and demolition work carried additional risks. When older construction containing asbestos-based joint compound was disturbed during remodeling, cutting, or demolition, previously encapsulated asbestos fibers could be released into the air. Workers performing renovation on structures built with asbestos-containing joint compound faced exposure risks even decades after the original construction was completed.

Asbestos-related diseases associated with joint compound exposure in litigation have included mesothelioma, lung cancer, asbestosis, and pleural disease. Mesothelioma—a rare and aggressive cancer of the lining surrounding the lungs and other organs—has been the disease most frequently cited in litigation involving asbestos-containing joint compound, given its strong causal link to asbestos fiber inhalation.

USG joint compound asbestos claims are handled through civil litigation rather than through an established asbestos bankruptcy trust fund. USG has not, as of available records, reorganized under Chapter 11 bankruptcy in connection with asbestos liability in the manner that created dedicated trust funds for many other asbestos manufacturers, meaning that claims against USG proceed through the tort system.

Filing through civil litigation: Plaintiffs diagnosed with mesothelioma, lung cancer, asbestosis, or other asbestos-related diseases who can document exposure to USG joint compound may pursue claims in civil court. Litigation records document that USG has been a named defendant in a substantial volume of asbestos personal injury and wrongful death cases. Plaintiffs alleged product liability on theories including failure to warn, negligence, and strict liability.

Statute of limitations: Asbestos claims are subject to statutes of limitations that vary by state, and the discovery rule—which typically begins the limitations clock when the plaintiff knew or reasonably should have known of the diagnosis and its potential cause—applies in most jurisdictions. Anyone with a potential claim should consult qualified legal counsel promptly following diagnosis.

Other liable parties: Because joint compound work occurred in the context of larger construction projects, multiple defendants are commonly named in asbestos litigation. Distributors, general contractors, premises owners, and manufacturers of other asbestos-containing products used on the same job sites may bear separate or shared liability. Some co-defendants in joint compound cases may have resolved into bankruptcy trusts, meaning a single claim may involve both trust fund filings and active litigation.

Legal consultation: Individuals who worked with or around USG joint compound and have received a diagnosis of an asbestos-related disease should contact an attorney with experience in asbestos litigation. Occupational history documentation, including job site records, co-worker affidavits, and union records, is typically important in establishing product identification and exposure in these cases.